UTI Ultra Short Duration Fund

Ticker: mf12704
Decent 48/100

☆ Add to Watchlist

More Options

Business Overview

UTI Ultra Short Duration Fund is a debt mutual fund designed for investors seeking stability and liquidity with a short investment horizon. Ideal for risk-averse individuals and those looking to park their funds for short periods, this fund aims to provide better returns than traditional savings accounts while maintaining capital safety. With a focus on high-quality debt instruments, it offers a balanced approach to wealth management.

  • Short-term investment option
  • Focus on capital preservation
  • Ideal for conservative investors
  • Potential for better returns than savings accounts
  • Invests in high-quality debt instruments
  • Liquidity for immediate financial needs
📊 Stock Investment Checklist (100 Points)
UTI Ultra Short Duration Fund • Updated: 2025-09-29 16:03:24
  • 10
    Business
    High
    The fund operates in a stable sector with a clear investment model, but lacks a significant competitive moat.
  • 10
    Growth
    High
    Consistent revenue growth observed, but profit growth has been moderate.
  • 10
    Profitability
    High
    ROE and ROCE are acceptable, but cash flow generation is inconsistent.
  • 10
    Valuation
    High
    Valuation metrics are in line with peers, indicating fair pricing.
  • 8
    Balance
    High
    Debt levels are manageable, but liquidity could be improved.
  • 7
    Governance
    High
    Promoter holding is stable, but there are minor concerns regarding disclosures.
  • 8
    Drivers
    High
    Growth drivers are present, but execution risks remain due to market volatility.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity affecting price action.
Final Score & Verdict
Score 48 / 100 • Decent
The UTI Ultra Short Duration Fund shows decent potential but faces challenges in profitability and liquidity. Investors should be cautious.


Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.